[CAS No.]654671-78-0
[Product]Januvia
[Alias]sitagliptin phosphate intermediates; 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate; (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate; 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine-phosphate
[Indications]: Used in type 2 diabetic patient;
Our newly development 3.1 class new drug 'Focalin XR tablet' will declare clinical research, interested enterprises please contact us.
Product Description:
Januvia is new drug, which can be used in the treatment of type 2 diabetes mellitus.